Target intelligence / Profile preview

Conserved oligomeric Golgi complex subunit 3 (COG3)

Target
COG3
Molecular classification
Other (Golgi tethering complex subunit, vesicle trafficking)
01

Overview

Conserved oligomeric Golgi complex subunit 3 (COG3) is an essential subunit of the conserved oligomeric Golgi (COG) complex, a multiprotein complex comprising eight subunits that is required for normal Golgi morphology and function. COG3 participates in the tethering of retrograde intra-Golgi vesicles, a key step prior to their fusion with Golgi cisternae, and is crucial for maintaining Golgi organization, dynamics, and appropriate protein glycosylation. Disruption of COG3 or the larger COG complex leads to Golgi fragmentation and multiple defects in protein glycosylation, underlying congenital disorders such as congenital disorder of glycosylation type IIbB. COG3 interacts functionally with other COG complex subunits to regulate vesicular trafficking between the ER and Golgi, and is not considered a classical drug target such as a receptor, enzyme, or transporter, but rather is a key component of the vesicle tethering apparatus within the Golgi apparatus[1][2][3][4].

Other names
SEC34COG complex subunit 3p94vesicle-docking protein SEC34 homologCDG2BBtethering factor SEC34
02

Biological functions

Maintenance of Golgi organization and functionER-Golgi transportRetrograde intra-Golgi vesicle tetheringProtein glycosylation
03

Disease associations

Congenital disorder of glycosylation type IIbBOther (potential roles in epilepsy and glycosylation-related defects)

Beyond the preview

Go deeper on Conserved oligomeric Golgi complex subunit 3 (COG3).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Conserved oligomeric Golgi complex subunit 3 (COG3).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call